mT2* and LIC in patients treated with DFX-DFO in combination followed by DFX monotherapy over 24 months. † indicates that month value was the last available value within each visit window, for example, days 1 to 210, 211 to 390, 391 to 570, and 571 to 750 for months 6, 12, 18, and 24, respectively, with the exception of month 12 mT2* where last observation carried forward was used. Hence, although 34 patients completed 24 months, 36 or 35 patients had an mT2* or LIC measurement within the visit window.